HIPAA / HITECH Compliance

Business Associate Agreement

Pursuant to 45 C.F.R. Parts 160 and 164

Version1.0
EffectiveUpon Execution
Governing LawNorth Carolina
DisputesBinding Arbitration
Table of Contents

This Business Associate Agreement ("Agreement") is entered into as of the Effective Date set forth in the signature block below, by and between the undersigned covered entity ("Covered Entity") and UMET Labs, LLC ("Business Associate"), a provider of AI-assisted clinical documentation services.

This Agreement is entered into pursuant to the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), as amended by the Health Information Technology for Economic and Clinical Health Act ("HITECH Act"), and their implementing regulations at 45 C.F.R. Parts 160 and 164 (collectively, "HIPAA Rules"). The parties intend for this Agreement to satisfy the applicable requirements of the HIPAA Rules and to govern Business Associate's use, disclosure, and safeguarding of Protected Health Information received from or created on behalf of Covered Entity.

Section 1

Definitions

Unless otherwise defined herein, all capitalized terms shall have the meanings set forth in the HIPAA Rules. For purposes of this Agreement:

Business AssociateUMET Labs, LLC, which performs services for or on behalf of Covered Entity that require access to PHI.
Covered EntityA HIPAA-covered health care provider, health plan, or health care clearinghouse that has engaged SnapNotes for services.
PHIProtected Health Information as defined at 45 C.F.R. § 160.103, including Electronic PHI (ePHI).
BreachThe acquisition, access, use, or disclosure of PHI in a manner not permitted under the HIPAA Rules that compromises the security or privacy of such information, as defined at 45 C.F.R. § 164.402.
Security IncidentThe attempted or successful unauthorized access, use, disclosure, modification, or destruction of information or interference with system operations in an information system, per 45 C.F.R. § 164.304.
SubcontractorAny person or entity to whom Business Associate delegates a function, activity, or service involving PHI.
Section 2

Obligations of Business Associate

2.1 Permitted Uses and Disclosures

Business Associate shall not use or disclose PHI other than as permitted or required by this Agreement, the underlying services agreement, or as required by law. Permitted uses include:

  1. uses and disclosures necessary to perform services for or on behalf of Covered Entity;
  2. uses for the proper management and administration of Business Associate, or to carry out its legal responsibilities, provided that any disclosures are required by law or Business Associate obtains reasonable assurances from the recipient that the PHI will be held confidentially; and
  3. uses for data aggregation services relating to the health care operations of Covered Entity, if expressly authorized in the underlying services agreement.
2.2 Safeguards

Business Associate shall implement administrative, physical, and technical safeguards that reasonably and appropriately protect the confidentiality, integrity, and availability of ePHI that it creates, receives, maintains, or transmits on behalf of Covered Entity, in accordance with 45 C.F.R. Part 164, Subpart C (Security Rule).

2.3 Reporting Obligations
  1. Breach Notification: Business Associate shall notify Covered Entity without unreasonable delay, and in no case later than thirty (30) calendar days after discovery, of any Breach of unsecured PHI, in accordance with 45 C.F.R. § 164.410. Notification shall include, to the extent reasonably possible, identification of each individual whose PHI was or is reasonably believed to have been involved.
  2. Security Incidents: Business Associate shall report to Covered Entity any successful Security Incident affecting ePHI promptly upon discovery.
  3. Unauthorized Disclosures: Business Associate shall report any use or disclosure of PHI not provided for by this Agreement of which it becomes aware.
2.4 Subcontractors

Business Associate shall ensure that any Subcontractor that creates, receives, maintains, or transmits PHI on behalf of Business Associate agrees to the same restrictions, conditions, and requirements that apply to Business Associate with respect to such PHI, in accordance with 45 C.F.R. § 164.504(e)(2)(ii)(D) and § 164.308(b)(2).

2.5 Designated Record Set

The parties acknowledge that Business Associate does not maintain Protected Health Information in a Designated Record Set, as defined at 45 C.F.R. § 164.501, on behalf of Covered Entity. SnapNotes functions solely as a documentation workflow tool; Covered Entity remains solely responsible for maintaining the official medical record in its electronic health record system or equivalent.

Accordingly, the individual rights obligations set forth at 45 C.F.R. §§ 164.524 (right of access) and 164.526 (right of amendment) do not apply to Business Associate, as Business Associate does not maintain PHI in a form that constitutes a Designated Record Set. Any request by an Individual for access to or amendment of records shall be directed to and handled exclusively by Covered Entity.

2.6 Accounting of Disclosures

Business Associate shall maintain and make available to Covered Entity the information required to provide an accounting of disclosures in accordance with 45 C.F.R. § 164.528. Such records shall be maintained for a minimum of six (6) years from the date of the disclosure.

2.7 Minimum Necessary

Business Associate shall make reasonable efforts to use, disclose, and request only the minimum necessary PHI to accomplish the intended purpose of the use, disclosure, or request, in accordance with 45 C.F.R. § 164.514(d).

2.8 Internal Practices and Audits

Business Associate shall make its internal practices, books, and records relating to the use and disclosure of PHI available to the Secretary of HHS for purposes of determining Covered Entity's compliance with the HIPAA Rules.

Section 3

Obligations of Covered Entity

Covered Entity shall:

  1. notify Business Associate of any limitation(s) in Covered Entity's Notice of Privacy Practices that may affect Business Associate's use or disclosure of PHI;
  2. notify Business Associate of any changes in, or revocation of, permission by an Individual to use or disclose PHI;
  3. notify Business Associate of any restriction on the use or disclosure of PHI to which Covered Entity has agreed; and
  4. not request Business Associate to use or disclose PHI in any manner that would not be permissible under the HIPAA Rules if done by Covered Entity.
Section 4

Term and Termination

4.1 Term

This Agreement shall be effective as of the Effective Date and shall remain in effect until terminated as set forth herein or until the underlying services agreement expires or is terminated.

4.2 Termination for Cause

Either party may terminate this Agreement immediately upon written notice if the other party has materially breached any provision of this Agreement and failed to cure such breach within thirty (30) days of receiving written notice specifying the breach in reasonable detail. Where cure is not possible, the non-breaching party may terminate immediately.

4.3 Effect of Termination

Upon termination for any reason, Business Associate shall, at Covered Entity's election, return or destroy all PHI in its possession. If return or destruction is not feasible, Business Associate shall provide written notice of the reasons and shall extend the protections of this Agreement to such PHI, limiting further uses and disclosures to those purposes that make return or destruction infeasible, for so long as Business Associate retains the PHI.

Section 5

Data Ownership

All PHI received from, or created or received by Business Associate on behalf of, Covered Entity remains the sole property of Covered Entity. Nothing in this Agreement shall be construed to grant Business Associate any ownership interest in, or intellectual property rights to, any PHI. Business Associate's stewardship of PHI does not confer any proprietary rights to such information.

Section 6

Indemnification

6.1 By Business Associate

Business Associate shall indemnify, defend, and hold harmless Covered Entity and its officers, directors, employees, and agents from and against any claims, losses, damages, fines, penalties, costs, and expenses (including reasonable attorneys' fees) arising out of or relating to Business Associate's breach of this Agreement or its obligations under the HIPAA Rules, to the extent such claims result from the negligent or wrongful acts or omissions of Business Associate.

6.2 By Covered Entity

Covered Entity shall indemnify, defend, and hold harmless Business Associate and its officers, directors, employees, and agents from and against any claims, losses, damages, fines, penalties, costs, and expenses (including reasonable attorneys' fees) arising out of or relating to Covered Entity's breach of this Agreement or its obligations under the HIPAA Rules, to the extent such claims result from the negligent or wrongful acts or omissions of Covered Entity.

6.3 Indemnification Procedure

The indemnified party shall: (a) promptly notify the indemnifying party in writing of any claim; (b) grant the indemnifying party sole control of the defense and settlement of the claim; and (c) provide reasonable cooperation and assistance. The indemnifying party shall not settle any claim in a manner that imposes obligations or liability on the indemnified party without prior written consent.

Section 7

Limitation of Liability

7.1 Cap on Liability

Except as set forth in Section 7.2, in no event shall either party's total aggregate liability to the other party under or in connection with this Agreement exceed the total fees paid or payable by Covered Entity to Business Associate in the twelve (12) months immediately preceding the event giving rise to the claim.

7.2 Exclusions from Cap

The limitation in Section 7.1 shall not apply to: (a) a party's indemnification obligations for third-party claims; (b) damages arising from a party's gross negligence or willful misconduct; or (c) a party's obligations to return or destroy PHI upon termination.

EXCLUSION OF CONSEQUENTIAL DAMAGES. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING LOST PROFITS OR LOSS OF BUSINESS, ARISING OUT OF OR RELATED TO THIS AGREEMENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS EXCLUSION SHALL NOT APPLY TO DAMAGES ARISING FROM GROSS NEGLIGENCE, WILLFUL MISCONDUCT, OR A PARTY'S BREACH OF ITS CONFIDENTIALITY OBLIGATIONS.
Section 8

Dispute Resolution

8.1 Informal Resolution

In the event of any dispute, claim, or controversy arising out of or relating to this Agreement (a "Dispute"), the parties shall first attempt to resolve the matter informally. Either party may initiate informal resolution by providing written notice of the Dispute to the other party. The parties shall negotiate in good faith for a period of thirty (30) days from the date of such notice (the "Negotiation Period") before initiating arbitration.

8.2 Binding Arbitration

If the parties are unable to resolve a Dispute during the Negotiation Period, the Dispute shall be submitted to and resolved exclusively by binding arbitration administered by the American Arbitration Association ("AAA") in accordance with its Commercial Arbitration Rules then in effect. The arbitration shall be conducted by a single arbitrator mutually agreed upon by the parties, or if the parties cannot agree, appointed by the AAA.

8.3 Arbitration Procedures
  1. Seat: The arbitration shall take place in Wilmington, North Carolina, unless the parties agree in writing to an alternative location or to conduct proceedings remotely.
  2. Governing Rules: The arbitration shall be governed by the Federal Arbitration Act (9 U.S.C. § 1 et seq.) and the AAA Commercial Arbitration Rules.
  3. Costs: Each party shall bear its own attorneys' fees and costs unless the arbitrator determines that a party has acted in bad faith, in which case the arbitrator may award fees to the prevailing party.
  4. Award: The arbitrator's award shall be final and binding, and judgment may be entered upon the award in any court of competent jurisdiction.
  5. Confidentiality: All arbitration proceedings, submissions, and awards shall be kept confidential to the fullest extent permitted by law.
8.4 Equitable Relief

Notwithstanding the foregoing, either party may seek emergency injunctive or other equitable relief from a court of competent jurisdiction to prevent irreparable harm, including unauthorized use or disclosure of PHI, without first engaging in the informal dispute resolution process or arbitration. Such an application shall not be deemed a waiver of the right to arbitrate the underlying Dispute.

8.5 Class Action Waiver

Each party waives any right to assert any claims against the other party as a plaintiff or class member in any class action or representative proceeding. The arbitrator shall have no authority to consolidate claims or to fashion a proceeding as a class or representative action.

Section 9

HITECH Act and Regulatory Compliance

The parties acknowledge their obligations under the HITECH Act, including without limitation the provisions of Subtitle D relating to privacy and security of PHI. Business Associate shall comply with all applicable provisions of the HITECH Act and any regulations promulgated thereunder by the U.S. Department of Health and Human Services. The parties agree to amend this Agreement as necessary to comply with any changes in applicable law or regulation, without further consideration required.

Section 10

Miscellaneous

10.1 Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of North Carolina, without regard to its conflict of law provisions, except to the extent preempted by federal law.

10.2 Entire Agreement

This Agreement constitutes the complete agreement between the parties with respect to the subject matter hereof and supersedes all prior negotiations, representations, warranties, and understandings with respect to such subject matter.

10.3 Severability

If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall continue in full force and effect.

10.4 Amendment

This Agreement may be amended only by a written instrument signed by authorized representatives of both parties, or as required by changes in applicable law.

10.5 No Third-Party Beneficiaries

Nothing in this Agreement is intended to create, nor shall it be construed to create, any rights in any third party, including any patient or Individual whose PHI may be subject to this Agreement.

10.6 Notices

All notices under this Agreement shall be in writing and delivered to the address set forth in the underlying services agreement, or to such other address as a party may designate in writing. Notice by email shall be deemed effective upon confirmation of receipt.

10.7 Counterparts; Electronic Signature

This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Electronic signatures shall be deemed valid and binding to the same extent as original signatures.

10.8 Waiver

No waiver of any right under this Agreement shall be deemed effective unless set forth in a written instrument signed by the waiving party. No waiver of any past breach shall constitute a waiver of any future breach.

Signatures

IN WITNESS WHEREOF, the parties have executed this Business Associate Agreement as of the Effective Date written below.

Covered Entity
Authorized Signature
Printed Name & Title
Organization Name
Date
UMET Labs, LLC — Business Associate
Authorized Signature
Printed Name & Title
UMET Labs, LLC
Date